0001567619-20-004369.txt : 20200219 0001567619-20-004369.hdr.sgml : 20200219 20200219213259 ACCESSION NUMBER: 0001567619-20-004369 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200214 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POLEWACZYK JAMES F CENTRAL INDEX KEY: 0001389046 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 20632366 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2020-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001389046 POLEWACZYK JAMES F ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive Vice President Common Stock 2020-02-14 4 M 0 207 0 A 16106 D Common Stock 2020-02-14 4 M 0 243 0 A 16349 D Common Stock 2020-02-14 4 M 0 150 0 A 16499 D Common Stock 2020-02-14 4 M 0 126 0 A 16625 D Common Stock 2020-02-14 4 M 0 127 0 A 16752 D Common Stock 2020-02-14 4 F 0 259 288.78 D 16493 D Non-Qualified Stock Option (right-to-buy) 288.78 2020-02-14 4 A 0 8906 A 2030-02-13 Common Stock 8906 8906 D Restricted Stock Unit 2020-02-14 4 A 0 866 A Common Stock 866 3147 D Restricted Stock Unit 2020-02-14 4 M 0 207 D Common Stock 2940 2940 D Restricted Stock Unit 2020-02-14 4 M 0 243 D Common Stock 243 2697 D Restricted Stock Unit 2020-02-14 4 M 0 150 D Common Stock 150 2547 D Restricted Stock Unit 2020-02-14 4 M 0 126 D Common Stock 126 2421 D Restricted Stock Unit 2020-02-14 4 M 0 127 D Common Stock 127 2294 D Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2021. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk 2020-02-19